https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/ias-international-aids-society-conference
PrEP (HIV Pre-Exposure Prophylaxis)

IAS (International AIDS Society) Conference

The Latest

woman using facebook app on phone

Meet Young People on Their Own Terms and Don’t Judge Their Sex Lives, Experts Agree

Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.

Asa Radix at IAS 2019

Taking Transgender Care From Research to Results

Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.

Samuel J. Bunting

Getting PrEP to People by Training Entire Health Teams

Primary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.

Conference Centre at 10th IAS Conference on HIV Science (IAS 2019), Mexico City, Mexico

Does Descovy Really Work Better Than Truvada for PrEP? One Researcher Raises Questions About the DISCOVER Trial Results

Newly presented data from IAS 2019 spark discussion about study populations, study endpoints, and potential weight gain.

Christoph D. Spinner

DISCOVER PrEP Trial Finds F/TAF Has Superior Load Time and Tail Compared to F/TDF

But given cost concerns, advocates question whether the benefits are enough to warrant dumping F/TDF as the go-to PrEP option.

Ivana Beesham

Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

PrEP Updates From the 9th International AIDS Society Conference on HIV Science Img

PrEP Updates From the 9th International AIDS Society Conference on HIV Science

Brief IAS 2017 summaries of ongoing research on pre-exposure prophylaxis (PrEP), evaluating its long-term effectiveness and safety, patient experiences, and alternative dosing schedules, such as an on-demand regimen.

Robert Grant on PrEP Dosing (Video) Img

Robert Grant on PrEP Dosing (Video)

PrEP is not intended for life, but as a way to bridge "seasons of risk" when people may be at a higher risk of contracting HIV, says Robert Grant, M.D., M.P.H., of the Gladstone Institutes.

Daily Dosing and Text Message Reminders Associated With PrEP Adherence in Gay Men Img

Daily Dosing and Text Message Reminders Associated With PrEP Adherence in Gay Men

Two studies presented at IAS 2015 offered a look at factors associated with adherence to PrEP in men who have sex with men (MSM).